tiprankstipranks
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Financial Statements

Compare
1,258 Followers

Entero Therapeutics Financial Overview

Entero Therapeutics's market cap is currently $2.38M. The company's EPS TTM is $-6.734; its P/E ratio is ―; Entero Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -29.27K$ -106.21K$ -537.40K$ -571.14K$ -976.98K
Operating Income$ -15.77M$ -12.68M$ -59.06M$ -26.43M-
EBITDA$ -15.74M$ -14.51M$ -57.99M$ -26.26M$ -13.77M
Net Income$ -15.79M$ -14.63M$ -58.54M$ -32.67M$ -15.18M
Balance Sheet
Cash & Short-Term Investments$ 3.71M$ 1.36M$ 8.25M$ 6.06M$ 0.00
Total Assets$ 6.88M$ 5.44M$ 11.79M$ 12.92M-
Total Debt$ 826.84K$ 883.71K$ 1.03M$ 628.95K-
Net Debt$ -2.88M$ -479.20K$ -7.22M$ -5.43M-
Total Liabilities$ 3.28M$ 2.70M$ 19.61M$ 15.56M-
Stockholders' Equity$ 3.60M$ 2.74M$ -7.82M$ -2.64M$ 0.00
Cash Flow
Free Cash Flow$ -12.88M$ -22.34M$ -42.61M$ -11.23M-
Operating Cash Flow$ -12.38M$ -22.34M$ -32.29M$ -11.22M-
Investing Cash Flow$ -500.00K$ 0.00$ -10.32M$ 87.35K-
Financing Cash Flow$ 15.23M$ 15.74M$ 44.76M$ 17.05M$ 13.14K
Currency in USD

Entero Therapeutics Earnings and Revenue History

Entero Therapeutics Debt to Assets

Entero Therapeutics Cash Flow

Entero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis